ABCD1 and adrenomyeloneuropathy: To investigate whether this new pathomechanism, identified in two mouse models with a glia-specific mutation, is also relevant for a human genetic disease, we analyzed ABCD1-deficient mice, a model for X-ALD/AMN (Forss-Petter et al., 1997).